GNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018

by GNS Healthcare | Oct 5, 2018 | Featured Posts, Press Releases

CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...

GNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer

by GNS Healthcare | Oct 3, 2018 | Featured Posts, Press Releases

CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...

The ALS Association Partners with GNS Healthcare to Apply AI to Accelerate Answer ALS Research

by GNS Healthcare | Jul 31, 2018 | Featured Posts, Press Releases

GNS Healthcare to combine its powerful, causal machine learning technology with the comprehensive Answer ALS patient datasets   Washington, D.C. and Cambridge, Mass. (July 31, 2018) – The ALS Association is providing new funding to allow GNS Healthcare to use...

GNS Healthcare Featured in Harvard Business Review Article on AI in the Workplace

by GNS Healthcare | Jul 1, 2018 | Featured Posts, News

GNS Healthcare is featured in the July/August issue of the Harvard Business Review as part of the article “Collaborative Intelligence: Humans and AI are Joining Forces”, a discussion of new digital tools and how AI can complement and augment human capabilities rather...

GNS Healthcare and Alliance for Clinical Trials in Oncology Present Results of Causal Modeling that Identifies Clinical and Molecular Drivers of Survival in Colorectal Cancer Patients

by GNS Healthcare | Jun 4, 2018 | Featured Posts, Press Releases

Results presented at ASCO 2018 Annual Meeting in Chicago show drivers at baseline allow better risk stratification at initiation of treatment CAMBRIDGE, Mass- June 4, 2018 – GNS Healthcare (GNS), a leading precision medicine company, together with the Alliance for...